The CCRA Advisory Board Welcomes Dr. Don Desserud
Effective January 1, 2020, Dr. Don Desserud begins his term as the Patient/Family Representative on the CCRA Advisory Board. Dr. Desserud participated in the 2019 Patient Involvement in Cancer Research Project (PIP) and is a survivor of Non-Hodgkin Lymphoma.
Dr. Desserud is a Political Science professor and researcher at the University of Prince Edward Island. He is very familiar with peer review and the research funding landscape in Canada. He also serves on three other boards: the Quality Assurance Committee at the Canadian Partnership Against Cancer, Health PEI’s Cancer Strategy Coordination Committee, and the PEI Electronic Synoptic Pathology Reporting Initiative (ESPRI) Committee.
We welcome Dr. Desserud and look forward to the contribution he will make to the CCRA going forward.

The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri...
Did you know that the CCRA is offering a free, all-ages cancer awareness event to people in the Halifax and surrounding communities on the afternoon of November 11 at the Halifax Convention Centre? Featuring exhibits from many organizations, thi...